Evidence map›Paper›PMID 39221218›Full record

ArticleMaterials today. Bio2024

Virucidal activity of porphyrin-based metal-organic frameworks against highly pathogenic coronaviruses and hepatitis C virus.

Orfeas-Evangelos Plastiras, Peggy Bouquet, Imelda Raczkiewicz, Sandrine Belouzard, Esther Martin De Fourchambault, Jeremy Dhainaut, Jean-Philippe Dacquin, Anne Goffard, Christophe Volkringer

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Membrane-Targeting Antivirals.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Orfeas-Evangelos PlastirasUnité de Catalyse et Chimie du Solide (UCCS), Univ. Lille, CNRS, Centrale Lille, Univ. Artois, F-59000, Lille, France.
Peggy BouquetClinical Microbiology Unit, Institut Pasteur de Lille, Lille, F-59000, France.
Imelda RaczkiewiczU1019, UMR 9017, CIIL - Center for Infection and Immunity of Lille, Institut Pasteur de Lille, Université de Lille, CNRS, INSERM, CHU de Lille, 59000, Lille, France.
Sandrine BelouzardU1019, UMR 9017, CIIL - Center for Infection and Immunity of Lille, Institut Pasteur de Lille, Université de Lille, CNRS, INSERM, CHU de Lille, 59000, Lille, France.
Esther Martin De FourchambaultU1019, UMR 9017, CIIL - Center for Infection and Immunity of Lille, Institut Pasteur de Lille, Université de Lille, CNRS, INSERM, CHU de Lille, 59000, Lille, France.
Jeremy DhainautUnité de Catalyse et Chimie du Solide (UCCS), Univ. Lille, CNRS, Centrale Lille, Univ. Artois, F-59000, Lille, France.
Jean-Philippe DacquinUnité de Catalyse et Chimie du Solide (UCCS), Univ. Lille, CNRS, Centrale Lille, Univ. Artois, F-59000, Lille, France.
Anne GoffardU1019, UMR 9017, CIIL - Center for Infection and Immunity of Lille, Institut Pasteur de Lille, Université de Lille, CNRS, INSERM, CHU de Lille, 59000, Lille, France.
Christophe VolkringerUnité de Catalyse et Chimie du Solide (UCCS), Univ. Lille, CNRS, Centrale Lille, Univ. Artois, F-59000, Lille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The antiviral effect of four porphyrin-based Metal-Organic Frameworks (PMOFs) with Al and Zr, namely Al-TCPP, PCN-222, PCN-223 and PCN-224 was assessed for the first time against HCoV-229E, two highly pathogenic coronaviruses (SARS-CoV-2 and MERS-CoV) and hepatitis C virus (HCV). Infection tests

Indexed as

AntiviralHCoV-229EHepatitis C virusMetal-organic frameworkSARS-CoV-2

Identifiers

PMID39221218
PMCPMC11364898

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.